Possible effectiveness of switching biologics from adalimumab to certolizumab pegol in pyoderma gangrenosum

J Dermatol. 2024 Aug 19. doi: 10.1111/1346-8138.17429. Online ahead of print.

Authors

Minoru Kimura¹, Akihiko Uchiyama¹, Yukie Endo¹, Masahito Yasuda¹, Sei-Ichiro Motegi¹

Affiliation

¹ Department of Dermatology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.

PMID: 39158177
DOI: 10.1111/1346-8138.17429

No abstract available

Publication types

Letter